CD274 and cancer: Furthermore, the latest experiments indicate that cancer patients [34] with intestinal flora disorders have a worse prognosis in the treatment with anti-PD-1/PD-L1 antibodies, which can be concluded that intestinal flora balance plays a vital role in the efficacy of PD-1/PD-L1 immunocheckpoint inhibitors.